CREATES Act passes House Committee
The House Energy and Commerce Committee yesterday unanimously passed H.R. 965, the “Creating and Restoring Equal Access to Equivalent Samples,” or CREATES Act of 2019, by a vote of 51-0.
The bill, which was introduced by Reps. David Cicilline, D-R.I., Jim Sensenbrenner, R-Wis., Jerrold Nadler, D-N.Y.), Doug Collins, R-Ga, Peter Welch, D-Vt., and David McKinley R-W.Va, would establish a process by which generic manufacturers could obtain sufficient quantities of brand drug samples for testing thereby deterring gaming of safety protocols that brand manufacturers use to delay or impede generic entry.
The Association for Accessible Medicines applauded the passage of the CREATES Act.
“We commend the leadership of chairman Frank Pallone, D-N.J., ranking member Greg Walden, R-Ore., Health Subcommittee chair Anna Eshoo, D-Calif. and Health Subcommittee ranking member Michael Burgess, R-Texas who forged strong bipartisan support for this bill, which helps enhance patient access to affordable generic and biosimilar medicines,” AAM said in a statement.
AAM continued, “Special recognition should be given to Reps. Peter Welch, D-Vt. and David McKinley, R-Va. who have tirelessly championed this legislation for years because it will help ease the burdens of patients paying for high-priced prescription medicines whose manufacturers have gamed the system to keep competitors off the market. Today’s vote is an important step along the path to providing patients with relief from high drug prices. We look forward to the House Judiciary Committee’s prompt consideration of the CREATES Act – where it enjoys strong bipartisan support – and its subsequent passage by the House of Representatives.”
No comments found